SLC52A3 and esophageal squamous cell carcinoma: Knockdown of SLC52A3 in ESCC cells results in inhibition of cell proliferation, colony formation and anchorage-independent growth, whereas overexpression of SLC52A3 in ESCC cells promotes cell proliferation, confers resistance to cisplatin and enhances tumorigenicity in nude mice [14].